Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are currently covering the company, MarketBeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock in the […]
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Free Report) have received a consensus recommendation of “Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the stock in […]
Olympiad Research LP increased its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 20.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 60,397 shares of the company’s stock after acquiring an additional 10,213 shares during the quarter. Olympiad […]
BioAtla (NASDAQ:BCAB – Free Report) had its price target cut by JMP Securities from $12.00 to $5.00 in a report issued on Thursday, Benzinga reports. They currently have a market outperform rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $7.00 price target on shares of BioAtla in a research […]
BioNTech SE (NASDAQ:BNTX – Free Report) – Research analysts at Leerink Partnrs issued their Q2 2024 earnings per share estimates for shares of BioNTech in a research report issued to clients and investors on Wednesday, May 22nd. Leerink Partnrs analyst D. Graybosch expects that the company will post earnings of ($1.76) per share for the […]